ABVC BioPharma Inc Forecast, price target & analysts
ABVC BioPharma Inc Target price 2025 - Analyst rating & recommendation
ABVC BioPharma Inc Classifications & Recommendation:
ABVC BioPharma Inc Price Target
| Target Price | $2.06 |
| Price | $2.89 |
| Deviation |
28.71%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target ABVC BioPharma Inc 2026 .
The average ABVC BioPharma Inc target price is $2.06.
This is
28.71%
register free of charge
$2.12
26.61%
register free of charge
$2.04
29.40%
register free of charge
|
|
| A rating was issued by 6 analysts: 0 Analysts recommend ABVC BioPharma Inc to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the ABVC BioPharma Inc stock has an average upside potential 2026 of
28.71%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.51 | 4.26 |
| 240.00% | 734.51% | |
| Net Margin | -960.78% | -266.68% |
| 81.50% | 72.24% |
3 Analysts have issued a sales forecast ABVC BioPharma Inc 2025 . The average ABVC BioPharma Inc sales estimate is
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $510k | 240.00% |
|---|---|---|
| 2025 |
$4.3m
734.51%
Unlock
|
|
3 ABVC BioPharma Inc Analysts have issued a net profit forecast 2025. The average ABVC BioPharma Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $-4.9m | 37.10% |
|---|---|---|
| 2025 |
$-11.4m
131.63%
Unlock
|
|
Net Margin
| 2024 | -960.78% | 81.50% |
|---|---|---|
| 2025 |
-266.68%
72.24%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.42 | -0.47 |
| 76.67% | 11.90% | |
| P/E | negative | |
| EV/Sales | 16.68 |
3 Analysts have issued a ABVC BioPharma Inc forecast for earnings per share. The average ABVC BioPharma Inc EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $-0.42 | 76.67% |
|---|---|---|
| 2025 |
$-0.47
11.90%
Unlock
|
|
P/E ratio
| Current | -17.00 | 2,031.13% |
|---|---|---|
| 2025 |
-6.16
63.76%
Unlock
|
|
Based on analysts' sales estimates for 2025, the ABVC BioPharma Inc stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 88.75 | 455.38% |
|---|---|---|
| 2025 |
16.68
81.20%
Unlock
|
|
P/S ratio
| Current | 87.79 | 584.57% |
|---|---|---|
| 2025 |
16.50
81.20%
Unlock
|
|
ABVC BioPharma Inc...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
